UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Total revenue	$ 685.3	$ 595.0
Total cost of revenue	325.6	288.7
Gross profit	359.7	306.3
Operating expenses:
Selling, general and administrative	162.7	145.7
Research and development	69.0	56.6
Other charges, net	5.3	7.5
Total operating expenses	237.0	209.8
Operating income	122.7	96.5
Interest and other income (expense), net	(16.1)	(2.5)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	106.6	94.0
Income tax provision	29.9	31.9
Equity in income of unconsolidated investees, net of tax	0.7	0.0
Consolidated net income	77.4	62.1
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.9	0.5
Net income attributable to Bruker Corporation	$ 76.5	$ 61.6
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.52	$ 0.41
Diluted	$ 0.52	$ 0.41
Weighted average common shares outstanding:
Basic	146.8	150.4
Diluted	147.6	151.4
Comprehensive income	$ 92.6	$ 53.2
Less: Comprehensive income attributable to noncontrolling interests	1.3	0.2
Less: Comprehensive loss attributable to redeemable noncontrolling interest	0.0	(0.2)
Comprehensive income attributable to Bruker Corporation	91.3	53.2
Product
Total revenue	567.1	490.4
Total cost of revenue	257.2	229.0
Service
Total revenue	115.5	103.2
Total cost of revenue	68.2	59.6
Other
Total revenue	2.7	1.4
Total cost of revenue	$ 0.2	$ 0.1